- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
Not specified
Clinical trial condition
Lymphoma, T-Cell
Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.
694 public trials
105 recruiting studies
Lymphoma, T-Cell trial results
Not Yet Recruiting
Long-term Assessment of Chlormethine Gel in Mycosis Fungoides
NCT07046663
- Conditions
- Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- AOU Ospedali Riuniti - Clinica di Ematologia Ancona, Italy
- SC Dermatologia, ASST-Papa Giovanni XXIII, Bergamo, Italy
- UO Dermatologia - IRCCS Policlinico S.Orsola-Malpighi Bologna, Italy
- UO Dermatologia ASST Spedali Civili Brescia Brescia, Italy
Not Yet Recruiting
Assessing An Oral JAK1 Inhibitor, Golidocitinib, in Patients Who Have Newly Diagnosed Peripheral T-Cell Lymphoma (JACKPOT23)
NCT07032532
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Sun Yat-sen University Cancer Center Guanzhou, Guangdong, China
Not Yet Recruiting
A Real-world Study on Golidocitinib-based Therapeutic Regimens for the Treatment of Patients With Peripheral T-cell Lymphoma
NCT06963632
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
Not specified
Not Yet Recruiting
A Study Comparing of P-GEMD Regimen Versus P-Gemox Regimen With Untreated Early-Stage NUAT or Advanced-Stage ENKTL.
NCT06953739
- Conditions
- Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +4 more
- Locations
-
Not specified
Not Yet Recruiting
The Value of PET Imaging Targeting Granzyme B in Predicting Efficacy and Prognosis in T-NK Cell Lymphoma
NCT06863441
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Lipid Metabolism Disorders, +16 more
- Locations
-
- Ruijin Hospital Affiliated to Shanghai Jiao Tong University Medical School, Shanghai Shanghai, Shanghai Municipality, China
NCT06757387
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
Not specified
Not Yet Recruiting
The Value of Artificial Intelligence-based 18F-FDG PET/CT in Diferential Diagnosis, Efficacy Prediction and Prognosis Prediction of T-NK Cell Lymphoma: a Clinical Study
NCT06747299
- Conditions
- Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +4 more
- Locations
-
- Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine Shanghai, Shanghai Municipality, China
Not Yet Recruiting
Linperlisib Combined With EZH2 Inhibitor in Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL)
NCT06712173
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
Not specified
Not Yet Recruiting
To Evaluate XNW5004 Tablets in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma
NCT06702605
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
Not specified